My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: usually no — compounded GLP‑1s are a risky last resort, not the best first option. Try appeals, manufacturer help, or other FDA‑approved alternatives first. If you still consider compounded product, do so only with extreme caution and from an accredited compounding pharmacy.

Why not compounded GLP‑1s as first choice

• Compounded GLP‑1 preparations are not FDA‑approved. That means no formal oversight of potency, purity, sterility or clinical bioequivalence to Wegovy.
• Quality problems, contamination, incorrect dosing and sterility failures have been reported with compounded injectables.
• Insurance nearly never covers compounded versions, and there’s little recourse if something goes wrong.
• Many doctors and professional societies warn against compounding biologic peptides unless there’s a clear, documented medical necessity.

What to try first (safer, often cheaper or insurable)

1. Appeal the coverage decision
   • Ask your prescriber to submit a prior‑authorization appeal or an exception request explaining your medical necessity (BMI, comorbidities, prior treatments tried and failed). This often works.
2. Check manufacturer assistance and savings
   • Novo Nordisk offers patient savings/cost‑support and a Patient Assistance Program for eligible patients. Contact Wegovy support (Novo Nordisk) or your prescriber’s office to get help enrolling.
3. Consider alternative FDA‑approved medications for weight
   • Zepbound (tirzepatide for weight) — FDA‑approved for obesity; some insurers will cover it differently than Wegovy.
   • Other GLP‑1s for diabetes that some people use under medical supervision: Ozempic (semaglutide), Rybelsus (oral semaglutide) or Mounjaro (tirzepatide) — coverage will depend on diagnosis and plan.
   • Non‑GLP‑1 prescription options: Qsymia (phentermine/topiramate), Contrave (bupropion/naltrexone), Xenical/Alli (orlistat).
   • Ask your clinician which of these your insurer is more likely to cover for your situation.
4. Compare cash prices and telemedicine clinics
   • Use GoodRx to compare out‑of‑pocket prices or find cash programs; reputable telehealth services (for example, Ro or Hims & Hers) can sometimes prescribe and offer transparent pricing or subscriptions — but confirm they use FDA‑approved drugs.
5. Look into clinical trials
   • Check clinicaltrials.gov for trials of GLP‑1 or new weight‑loss drugs in your area — you may qualify for free or low‑cost treatment.

If you still consider a compounded GLP‑1

• Only use a compounding pharmacy that is accredited by the Pharmacy Compounding Accreditation Board (PCAB). Verify accreditation at pcab.org.
• Ask the pharmacy for:
  • Certificate of analysis (COA) showing identity and potency of the active ingredient.
  • Sterility testing results and details on how they source the bulk active pharmaceutical ingredient.
  • Written storage, handling and injection instructions.
• Discuss with your prescriber the clear risks (infection, incorrect dose, unknown bioequivalence) and document that you were counseled.
• Realize you’re taking on safety and legal risk; many clinicians will refuse to prescribe compounded versions for that reason.

Bottom line Start with an appeal and manufacturer assistance or explore other FDA‑approved therapies (Zepbound, Ozempic/Mounjaro with appropriate diagnosis, or non‑GLP‑1 options) before turning to compounded GLP‑1s. If you decide to go compounded, insist on a PCAB‑accredited pharmacy and full testing documentation, and discuss risks with your clinician.

If you want, tell me:

• whether you have commercial insurance, Medicare/Medicaid, or are uninsured;
• any prior weight‑loss meds you’ve tried and why they didn’t work; and I’ll suggest the most practical next step and exact wording your prescriber can use for an appeal.